[The CRO concept is active and Baihua Pharmaceutical is trading at the daily limit] On September 29, the CRO concept was active and Baihua Pharmaceutical was trading at the daily limit. Nearshore protein rose by more than 10%, with Yinuosi, Pharmaron and Asymphysics following the rise. On the news, Caitong Securities Research reported that domestic pharmaceutical companies’ overseas licensing transactions for new drugs have driven the gradual recovery of investment and financing, and the demand for biotech research and development has rebounded. The AI ​​pharmaceutical transmission chain has entered a forward cycle, and the model of iteration from accelerated design to wet experiment verification and back-infusion AI model has been initially established, taking the lead in benefiting upstream protein synthesis, pre-clinical CRO and other links.